Evidence map›Paper›PMID 41623716›Full record

ArticleDigital health

Enhancing early prediction of pathological complete response in breast cancer using attention-based convolutional neural networks in digital pathology.

Maria Colomba Comes, Andrea Lupo, Arianna Bozzi, Annarita Fanizzi, Angelo Cirillo, Giorgio De Nunzio, Maria Irene Pastena, Alessandro Rizzo, Deniz Can Guven, Elsa Vitale and 3 more

Abstract read
In one paragraph

Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Maria Colomba ComesLaboratorio di Biostatistica e Bioinformatica, IRCCS Istituto Tumori "Giovanni Paolo II," Bari, Italy.
Andrea LupoLaboratorio di Biostatistica e Bioinformatica, IRCCS Istituto Tumori "Giovanni Paolo II," Bari, Italy.ORCID https://orcid.org/0009-0004-4859-6226
Arianna BozziLaboratorio di Biostatistica e Bioinformatica, IRCCS Istituto Tumori "Giovanni Paolo II," Bari, Italy.ORCID https://orcid.org/0009-0006-1030-8676
Annarita FanizziLaboratorio di Biostatistica e Bioinformatica, IRCCS Istituto Tumori "Giovanni Paolo II," Bari, Italy.
Angelo CirilloDirezione Generale, IRCCS Istituto Tumori "Giovanni Paolo II," Bari, Italy.
Giorgio De NunzioLaboratorio di Fisica Biomedica e Ambientale, Department of Mathematics and Physics "E. De Giorgi" Università del Salento, Lecce, Italy.
Maria Irene PastenaUnità Operativa Complessa di Anatomia Patologica, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II," Bari, Italy.
Alessandro RizzoUnità Operativa Complessa di Oncologia Medica, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II," Bari, Italy.
Deniz Can GuvenDepartment of Medical Oncology, Hacettepe University, Cancer Institute, Ankara, Turkey.
Elsa VitaleDirezione Scientifica, IRCCS Istituto Tumori "Giovanni Paolo II," Bari, Italy.
Francesco Alfredo ZitoUnità Operativa Complessa di Anatomia Patologica, I.R.C.C.S. Istituto Tumori "Giovanni Paolo II," Bari, Italy.
Samantha BoveLaboratorio di Biostatistica e Bioinformatica, IRCCS Istituto Tumori "Giovanni Paolo II," Bari, Italy.
Raffaella MassafraLaboratorio di Biostatistica e Bioinformatica, IRCCS Istituto Tumori "Giovanni Paolo II," Bari, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To develop an attention-based convolutional neural network (CNN) pipeline for early prediction of pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in breast cancer, improving feature selection and interpretability in whole slide image (WSI) analysis. Methods: A retrospective analysis was conducted on 384,076 tiles extracted from 122 Hematoxylin and Eosin-stained WSIs, divided among an investigational cohort (IC, 82 patients enrolled at IRCCS Istituto Tumori "Giovanni Paolo II"), a validation cohort (VC, 20 patients, same Institution), and an external validation cohort (EVC, 20 patients belonging the Yale trastuzumab response cohort public dataset). WSIs were first annotated and then automatically segmented into tiles. Noninformative regions were filtered using Mini-Batch C-Fuzzy K-Means. Remaining tiles were analyzed using a CNN with a Convolutional Block Attention Module, prioritizing both histological features and tiles critical for predicting pCR. Results: The model achieved robust performance: 81.4% AUC, 81.3% accuracy, 80.0% specificity, and 83.3% sensitivity in IC; 80.9% AUC, 80.0% accuracy, 85.78% specificity, and 66.7% sensitivity in VC; and 76.2% AUC, 70.0% accuracy, 71.4% specificity, and 66.7% sensitivity in EVC. The EVC, consisting of WSIs at 20× magnification compared to the 40× magnification of IC and VC, demonstrated the model's robustness to varying resolutions. Conclusion: This is an innovative pipeline that not only improves prediction but also enhances the clinical utility of digital pathology.

Indexed as

attention-based convolutional neural networksbreast cancer early predictiondigital pathologyneoadjuvant chemotherapyPathological complete response

Identifiers

PMID41623716
PMCPMC12855765

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.